Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-024076

Chief Scientific Officer sold 5,000 shares at an average $46.34 ($231,716)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DiRaimondo Thomas Chief Scientific Officer 2024-09-27 Sale 10b5-1 −4,325 $46.21 $199,840 98,613 D
DiRaimondo Thomas Chief Scientific Officer 2024-09-27 Sale 10b5-1 −675 $47.22 $31,877 97,938 D
Open-market sales · 5,000 sh · avg $46.34 · $231,716
Loading xslF345X05/form4-09272024_110948.xml…